- Home
- ELMD vs RNAC Comparison
ELMD vs RNAC Comparison
Compare ELMD & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | RNAC |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.1M | 168.3M |
| IPO Year | 2010 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ELMD | RNAC |
|---|---|---|
| Price | $25.58 | $6.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $36.00 | $34.00 |
| AVG Volume (30 Days) | 25.2K | ★ 155.9K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $54,716,000.00 | $2,797,000.00 |
| Revenue This Year | $15.59 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | $45.97 | ★ N/A |
| Revenue Growth | ★ 13.83 | N/A |
| 52 Week Low | $17.73 | $5.60 |
| 52 Week High | $30.73 | $14.56 |
Technical Indicators
Market Signals| Indicator | ELMD | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 43.80 |
| Support Level | $23.29 | $5.87 |
| Resistance Level | $26.84 | $6.60 |
| Average True Range (ATR) | 0.77 | 0.45 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 41.40 | 20.47 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.